LaPlant B - Search Results

1

MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)?

Shanafelt TD, Kay NE, Call TG, Zent CS, Jelinek DF, LaPlant B, Morice WG, Hanson CA. Shanafelt TD, et al. Among authors: laplant b. Leuk Res. 2008 Sep;32(9):1458-61. doi: 10.1016/j.leukres.2007.11.030. Epub 2008 Jan 7. Leuk Res. 2008. PMID: 18179821 Free PMC article.

2

Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test.

Nowakowski GS, Hoyer JD, Shanafelt TD, Geyer SM, LaPlant BR, Call TG, Jelinek DF, Zent CS, Kay NE. Nowakowski GS, et al. Mayo Clin Proc. 2007 Apr;82(4):449-53. doi: 10.4065/82.4.449. Mayo Clin Proc. 2007. PMID: 17418074

3

CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential.

Shanafelt TD, Geyer SM, Bone ND, Tschumper RC, Witzig TE, Nowakowski GS, Zent CS, Call TG, Laplant B, Dewald GW, Jelinek DF, Kay NE. Shanafelt TD, et al. Among authors: laplant b. Br J Haematol. 2008 Mar;140(5):537-46. doi: 10.1111/j.1365-2141.2007.06965.x. Br J Haematol. 2008. PMID: 18275431 Free PMC article.

4

Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia.

Palmer S, Hanson CA, Zent CS, Porrata LF, Laplant B, Geyer SM, Markovic SN, Call TG, Bowen DA, Jelinek DF, Kay NE, Shanafelt TD. Palmer S, et al. Among authors: laplant b. Br J Haematol. 2008 May;141(5):607-14. doi: 10.1111/j.1365-2141.2008.07070.x. Epub 2008 Apr 1. Br J Haematol. 2008. PMID: 18384436 Free PMC article.

5

Karyotype evolution on fluorescent in situ hybridization analysis is associated with short survival in patients with chronic lymphocytic leukemia and is related to CD49d expression.

Shanafelt TD, Hanson C, Dewald GW, Witzig TE, LaPlant B, Abrahamzon J, Jelinek DF, Kay NE. Shanafelt TD, et al. Among authors: laplant b. J Clin Oncol. 2008 May 10;26(14):e5-6. doi: 10.1200/JCO.2008.16.7874. J Clin Oncol. 2008. PMID: 18467710 Free PMC article. No abstract available.

6

Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab.

Zent CS, Secreto CR, LaPlant BR, Bone ND, Call TG, Shanafelt TD, Jelinek DF, Tschumper RC, Kay NE. Zent CS, et al. Leuk Res. 2008 Dec;32(12):1849-56. doi: 10.1016/j.leukres.2008.05.014. Epub 2008 Jun 27. Leuk Res. 2008. PMID: 18584865 Free PMC article. Clinical Trial.

7

Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.

Zent CS, Call TG, Shanafelt TD, Tschumper RC, Jelinek DF, Bowen DA, Secreto CR, Laplant BR, Kabat BF, Kay NE. Zent CS, et al. Cancer. 2008 Oct 15;113(8):2110-8. doi: 10.1002/cncr.23824. Cancer. 2008. PMID: 18759253 Free PMC article. Clinical Trial.

8

Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia.

Nowakowski GS, Hoyer JD, Shanafelt TD, Zent CS, Call TG, Bone ND, Laplant B, Dewald GW, Tschumper RC, Jelinek DF, Witzig TE, Kay NE. Nowakowski GS, et al. Among authors: laplant b. J Clin Oncol. 2009 Apr 10;27(11):1844-9. doi: 10.1200/JCO.2008.17.0795. Epub 2009 Mar 2. J Clin Oncol. 2009. PMID: 19255329 Free PMC article.

9

N9986: a phase II trial of thalidomide in patients with relapsed chronic lymphocytic leukemia.

Kay NE, Shanafelt TD, Call TG, Wu W, Laplant BR. Kay NE, et al. Leuk Lymphoma. 2009 Apr;50(4):588-92. doi: 10.1080/10428190902777467. Leuk Lymphoma. 2009. PMID: 19373657 Free PMC article. Clinical Trial.

10

Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia.

Shanafelt TD, Call TG, Zent CS, LaPlant B, Bowen DA, Roos M, Secreto CR, Ghosh AK, Kabat BF, Lee MJ, Yang CS, Jelinek DF, Erlichman C, Kay NE. Shanafelt TD, et al. Among authors: laplant b. J Clin Oncol. 2009 Aug 10;27(23):3808-14. doi: 10.1200/JCO.2008.21.1284. Epub 2009 May 26. J Clin Oncol. 2009. PMID: 19470922 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

93 results

Search Page